Accelerated CCL 4-induced liver fibrosis in Hjv-/- mice, associated with an oxidative burst and precocious profibrogenic gene expression

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Sebastiani, Giada ^a,b   Gkouvatsos, Kostas ^a,b   Maffettone, Carmen ^a,b   Busatto, Graziella ^c   Guido, Maria ^c,d   Pantopoulos, Kostas ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF PADOVA   (Italy)

^d Pathology Department   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA SMOOTH MUSCLE ACTIN; ALPHA SMOOTH MUSCLE ACTIN ANTIBODY; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; COLLAGEN TYPE 1; ENDOTHELIN 1; FERRITIN; HEPCIDIN; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR; PROTEIN ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; HFE2 PROTEIN, MOUSE; MEMBRANE PROTEIN;

ACUTE DISEASE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL ACTIVATION; CONTROLLED STUDY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; FERRITIN BLOOD LEVEL; FIBROGENESIS; GENE CONTROL; GENE EXPRESSION; HEMOCHROMATOSIS; IMMUNOREACTIVITY; LIVER FIBROSIS; LIVER INJURY; LIVER NECROSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RESPIRATORY BURST; STELLATE CELL; UPREGULATION; WILD TYPE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; GENETICS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; METABOLISM; MOUSE MUTANT; PATHOLOGY; POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANIMALIA; MUS;

ANIMALS; BLOTTING, WESTERN; CARBON TETRACHLORIDE; ENDOTHELIN-1; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CIRRHOSIS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; PLATELET-DERIVED GROWTH FACTOR; POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 80053085583     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0025138     Document Type: Article

References (54)

1. Galaris D, Pantopoulos K, (2008) Oxidative stress and iron homeostasis: mechanistic and health aspects. Crit Rev Clin Lab Sci 45: 1-23.
2. Pietrangelo A, (2004) Hereditary hemochromatosis- a new look at an old disease. N Engl J Med 350: 2383-2397.
3. Weiss G, (2010) Genetic mechanisms and modifying factors in hereditary hemochromatosis. Nat Rev Gastroenterol Hepatol 7: 50-58.
4. Beutler E, (2006) Hemochromatosis: genetics and pathophysiology. Annu Rev Med 57: 331-347.
5. De Domenico I, McVey Ward D, Kaplan J, (2008) Regulation of iron acquisition and storage: consequences for iron-linked disorders. Nat Rev Mol Cell Biol 9: 72-81.
6. Nemeth E, Ganz T, (2009) The role of hepcidin in iron metabolism. Acta Haematol 122: 78-86.
7. Andrews NC, Schmidt PJ, (2007) Iron homeostasis. Annu Rev Physiol 69: 69-85.
8. Lee PL, Beutler E, (2009) Regulation of hepcidin and iron-overload disease. Annu Rev Pathol 4: 489-515.
9. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, et al. (1996) A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13: 399-408.
10. Papanikolaou G, Samuels ME, Ludwig EH, MacDonald ML, Franchini PL, et al. (2004) Mutations in HFE2 cause iron overload in chromosome 1q-linked juvenile hemochromatosis. Nat Genet 36: 77-82.
11. Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, et al. (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet 38: 531-539.
12. Kowdley KV, (2004) Iron, hemochromatosis, and hepatocellular carcinoma. Gastroenterology 127: S79-86.
13. Ramm GA, Ruddell RG, (2005) Hepatotoxicity of iron overload: mechanisms of iron-induced hepatic fibrogenesis. Semin Liver Dis 25: 433-449.
14. Liver EAFTSOT (2010) EASL clinical practice guidelines for HFE hemochromatosis. J Hepatol 53: 3-22.
15. Fracanzani AL, Piperno A, Valenti L, Fraquelli M, Coletti S, et al. (2010) Hemochromatosis in Italy in the last 30 years: role of genetic and acquired factors. Hepatology 51: 501-510.
16. Alla V, Bonkovsky HL, (2005) Iron in nonhemochromatotic liver disorders. Semin Liver Dis 25: 461-472.
17. Sebastiani G, Walker AP, (2007) HFE gene in primary and secondary hepatic iron overload. World J Gastroenterol 13: 4673-4689.
18. Friedman SL, (2008) Mechanisms of hepatic fibrogenesis. Gastroenterology 134: 1655-1669.
19. Rippe RA, Brenner DA, (2004) From quiescence to activation: Gene regulation in hepatic stellate cells. Gastroenterology 127: 1260-1262.
20. Iredale JP, (2007) Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117: 539-548.
21. Constandinou C, Henderson N, Iredale JP, (2005) Modeling liver fibrosis in rodents. Methods Mol Med 117: 237-250.
22. Weiler-Normann C, Herkel J, Lohse AW, (2007) Mouse models of liver fibrosis. Z Gastroenterol 45: 43-50.
23. Arezzini B, Lunghi B, Lungarella G, Gardi C, (2003) Iron overload enhances the development of experimental liver cirrhosis in mice. Int J Biochem Cell Biol 35: 486-495.
24. Mackinnon M, Clayton C, Plummer J, Ahern M, Cmielewski P, et al. (1995) Iron overload facilitates hepatic fibrosis in the rat alcohol/low-dose carbon tetrachloride model. Hepatology 21: 1083-1088.
25. Tsukamoto H, Horne W, Kamimura S, Niemela O, Parkkila S, et al. (1995) Experimental liver cirrhosis induced by alcohol and iron. J Clin Invest 96: 620-630.
26. Asare GA, Bronz M, Naidoo V, Kew MC, (2008) Synergistic interaction between excess hepatic iron and alcohol ingestion in hepatic mutagenesis. Toxicology 254: 11-18.
27. Wang GS, Eriksson LC, Xia L, Olsson J, Stal P, (1999) Dietary iron overload inhibits carbon tetrachloride-induced promotion in chemical hepatocarcinogenesis: effects on cell proliferation, apoptosis, and antioxidation. J Hepatol 30: 689-698.
28. Olynyk J, Hall P, Reed W, Williams P, Kerr R, et al. (1995) A long-term study of the interaction between iron and alcohol in an animal model of iron overload. J Hepatol 22: 671-676.
29. Carthew P, Dorman BM, Edwards RE, Francis JE, Smith AG, (1993) A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron overload. Lab Invest 69: 217-222.
30. Pietrangelo A, Gualdi R, Casalgrandi G, Montosi G, Ventura E, (1995) Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J Clin Invest 95: 1824-1831.
31. Huang FW, Pinkus JL, Pinkus GS, Fleming MD, Andrews NC, (2005) A mouse model of juvenile hemochromatosis. J Clin Invest 115: 2187-2191.
32. Niederkofler V, Salie R, Arber S, (2005) Hemojuvelin is essential for dietary iron sensing, and its mutation leads to severe iron overload. J Clin Invest 115: 2180-2186.
33. Weiss G, Goodnough LT, (2005) Anemia of chronic disease. N Engl J Med 352: 1011-1023.
34. Hider RC, (2002) Nature of nontransferrin-bound iron. Eur J Clin Invest 32 (Suppl 1): 50-54.
35. Krijt J, Vokurka M, Chang KT, Necas E, (2004) Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin. Blood 104: 4308-4310.
36. Park CH, Bacon BR, Brittenham GM, Tavill AS, (1987) Pathology of dietary carbonyl iron overload in rats. Lab Invest 57: 555-563.
37. Xiong S, She H, Sung CK, Tsukamoto H, (2003) Iron-dependent activation of NF-kappaB in Kupffer cells: a priming mechanism for alcoholic liver disease. Alcohol 30: 107-113.
38. Xiong S, She H, Takeuchi H, Han B, Engelhardt JF, et al. (2003) Signaling role of intracellular iron in NF-kappaB activation. J Biol Chem 278: 17646-17654.
39. Weiss G, (2009) Iron metabolism in the anemia of chronic disease. Biochim Biophys Acta 1790: 682-693.
40. Ueberham E, Low R, Ueberham U, Schonig K, Bujard H, et al. (2003) Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis. Hepatology 37: 1067-1078.
41. De Domenico I, Zhang TY, Koening CL, Branch RW, London N, et al. (2010) Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J Clin Invest 120: 2395-2405.
42. Ruddell RG, Hoang-Le D, Barwood JM, Rutherford PS, Piva TJ, et al. (2009) Ferritin functions as a proinflammatory cytokine via iron-independent protein kinase C zeta/nuclear factor kappaB-regulated signaling in rat hepatic stellate cells. Hepatology 49: 887-900.
43. Lee P, Peng H, Gelbart T, Wang L, Beutler E, (2005) Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci USA 102: 1906-1910.
44. Houglum K, Ramm GA, Crawford DH, Witztum JL, Powell LW, et al. (1997) Excess iron induces hepatic oxidative stress and transforming growth factor beta1 in genetic hemochromatosis. Hepatology 26: 605-610.
45. Ramm GA, Crawford DH, Powell LW, Walker NI, Fletcher LM, et al. (1997) Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy. J Hepatol 26: 584-592.
46. Houglum K, Filip M, Witztum JL, Chojkier M, (1990) Malondialdehyde and 4-hydroxynonenal protein adducts in plasma and liver of rats with iron overload. J Clin Invest 86: 1991-1998.
47. Gualdi R, Casalgrandi G, Montosi G, Ventura E, Pietrangelo A, (1994) Excess iron into hepatocytes is required for activation of collagen type I gene during experimental siderosis. Gastroenterology 107: 1118-1124.
48. Pietrangelo A, Gualdi R, Casalgrandi G, Geerts A, De Bleser P, et al. (1994) Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology 19: 714-721.
49. Pietrangelo A, Rocchi E, Schiaffonati L, Ventura E, Cairo G, (1990) Liver gene expression during chronic dietary iron overload in rats. Hepatology 11: 798-804.
50. Lebeau A, Frank J, Biesalski HK, Weiss G, Srai SK, et al. (2002) Long-term sequelae of HFE deletion in C57BL/6 x 129/O1a mice, an animal model for hereditary haemochromatosis. Eur J Clin Invest 32: 603-612.
51. Riemer J, Hoepken HH, Czerwinska H, Robinson SR, Dringen R, (2004) Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal Biochem 331: 370-375.
52. Lewis JH, Kleiner DE, (2006) Hepatic injury due to drugs, chemicals and toxins. In: Burt AD PB, Ferrel LD, editors. MacSween's Pathology of the Liver. 5th ed Churchill Livingstone pp. 650-759.
53. Sebastiani G, Vario A, Ferrari A, Pistis R, Noventa F, et al. (2006) Hepatic iron, liver steatosis and viral genotypes in patients with chronic hepatitis C. J Viral Hepat 13: 199-205.
54. Maffettone C, Chen G, Drozdov I, Ouzounis C, Pantopoulos K, (2010) Tumorigenic properties of iron regulatory protein 2 (IRP2) mediated by its specific 73-amino acids insert. PLoS One 5: e10163.